Literature DB >> 2831868

Antigenic diversity of infectious bursal disease viruses.

D H Jackwood1, Y M Saif.   

Abstract

Statistically significant antigenic differences were detected among serotype I infectious bursal disease viruses (IBDV) using the virus-neutralization test. Eight serotype I commercial vaccine strains, five serotype I field strains, and two serotype II field strains were tested. Hyperimmune guinea pig antisera against heterologous and homologous IBDV strains were used in cross-neutralization tests. Relatedness values were calculated from geometric mean antibody titers based on a minimum of three tests. Six subtypes were distinguished among the 13 serotype I strains tested.

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2831868

Source DB:  PubMed          Journal:  Avian Dis        ISSN： 0005-2086            Impact factor:   1.577


  33 in total

1.  Naturally occurring-neutralizing monoclonal antibody escape variants define the epidemiology of infectious bursal disease viruses in the United States.

Authors:  D B Snyder; V N Vakharia; P K Savage
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Phylogenetic analysis reveals a correlation between the expansion of very virulent infectious bursal disease virus and reassortment of its genome segment B.

Authors:  Chung-Chau Hon; Tsan-Yuk Lam; Alexei Drummond; Andrew Rambaut; Yiu-Fai Lee; Chi-Wai Yip; Fanya Zeng; Pui-Yi Lam; Patrick T W Ng; Frederick C C Leung
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  One-step RT-PCR for the detection of infectious bursal disease virus in clinical samples.

Authors:  R S Kataria; A K Tiwari; T Nanthakumar; P P Goswami
Journal:  Vet Res Commun       Date:  2001-07       Impact factor: 2.459

Review 4.  Economically important non-oncogenic immunosuppressive viral diseases of chicken--current status.

Authors:  V Balamurugan; J M Kataria
Journal:  Vet Res Commun       Date:  2006-07       Impact factor: 2.459

5.  Hypericum perforatum extract therapy for chickens experimentally infected with infectious bursal disease virus and its influence on immunity.

Authors:  Ruofeng Shang; Cheng He; Jiongran Chen; Xiuying Pu; Yu Liu; Lanying Hua; Ling Wang; Jianping Liang
Journal:  Can J Vet Res       Date:  2012-07       Impact factor: 1.310

6.  Detection of infectious bursal disease viruses by using cloned cDNA probes.

Authors:  D J Jackwood; F S Kibenge; C C Mercado
Journal:  J Clin Microbiol       Date:  1989-11       Impact factor: 5.948

7.  Biological roles of the major capsid proteins and relationships between the two existing serotypes of infectious bursal disease virus.

Authors:  S K Reddy; A Silim; M J Ratcliffe
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

8.  Epitope mapping of capsid proteins VP2 and VP3 of infectious bursal disease virus.

Authors:  T Yamaguchi; K Iwata; M Kobayashi; M Ogawa; H Fukushi; K Hirai
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  Infectious bursal disease virus structural protein VP2 expressed by a fowlpox virus recombinant confers protection against disease in chickens.

Authors:  H G Heine; D B Boyle
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Expression of immunogenic VP2 protein of infectious bursal disease virus in Arabidopsis thaliana.

Authors:  H Wu; N K Singh; R D Locy; K Scissum-Gunn; J J Giambrone
Journal:  Biotechnol Lett       Date:  2004-05       Impact factor: 2.461
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.